Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. United States Connected Drug Delivery Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Connected Sensors v/s Integrated Connected Devices)
5.2.2. By Technology (Bluetooth, Near Field Communication, Others)
5.2.3. By Application (Asthma & COPD, Diabetes, Others)
5.2.4. By End User (Healthcare Providers v/s Homecare)
5.2.5. By Company (2022)
5.2.6. By Region
5.3. Product Market Map
5.3.1. By Product Type
5.3.2. By Technology
5.3.3. By Application
5.3.4. By End User
5.3.5. By Region
6. North-East Connected Drug Delivery Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User
7. Mid-West Connected Drug Delivery Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
8. South Connected Drug Delivery Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
9. West Connected Drug Delivery Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Competitive Landscape
12.1. Abbott Laboratories, Inc.
12.2. F. Hoffmann-La Roche Ltd. (USA)
12.3. Reciprocal Labs Corporation (Propeller Health)
12.4. Teva USA
12.5. Merck & Co.
12.6. West Pharmaceutical Services, Inc.
12.7. Molex LLC (Phillips Medisize)
12.8. Cohero Health, Inc.
12.9. Becton, Dickinson, and Company
12.10. Unilife Corporation
13. Strategic Recommendations